Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 May;85(9):3170–3174. doi: 10.1073/pnas.85.9.3170

Protection against the staphylococcal enterotoxin-induced intestinal disorder in the monkey by anti-idiotypic antibodies.

B Reck 1, P H Scheuber 1, W Londong 1, B Sailer-Kramer 1, K Bartsch 1, D K Hammer 1
PMCID: PMC280165  PMID: 3362865

Abstract

The staphylococcal enterotoxin serotype B (SEB)-induced enteric intoxication and the immediate-type reaction in the skin of unsensitized monkeys was used to define whether agents competing with SEB for target cell receptors may inhibit pathophysiological effects. For this purpose a duodenal provocation test was developed by use of a pediatric gastroscope, allowing the evaluation of the influence of antagonists on the intestinal disorder upon SEB challenge at the same duodenal site. First, carboxymethylation of histidine residues of SEB caused a complete loss of emetic and skin-sensitizing activity without changing the immunological specificity. However, carboxymethylated SEB is a strong inhibitor of enteric intoxications and immediate-type skin reactions upon SEB challenge. Second, after immunization of BALB/c mice with monoclonal anti-SEB antibodies, monoclonal antiidiotypic antibodies (anti-Id) were obtained by the "hybridoma technique" and purification by idiotype-affinity chromatography. Anti-Id specifically inhibited the binding of horseradish peroxidase-labeled anti-SEB to the ligand, and SEB blocked as well the interaction of these two antibody species, indicating a high degree of binding-site selectivity. Anti-Id completely protected against emetic response and diarrhea upon duodenal provocation with SEB and inhibited immediate-type skin reactions as well. Further, anti-Id acted as an antagonist without triggering biologic functions themselves. This shows that anti-Id constitute a useful tool to protect against a bacterial toxin-induced intestinal disorder.

Full text

PDF
3170

Images in this article

3171Image
on p.3171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamberger U., Scheuber P. H., Sailer-Kramer B., Bartsch K., Hartmann A., Beck G., Hammer D. K. Anti-idiotypic antibodies that inhibit immediate-type skin reactions in unsensitized monkeys on challenge with staphylococcal enterotoxin. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7054–7058. doi: 10.1073/pnas.83.18.7054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CRESTFIELD A. M., STEIN W. H., MOORE S. Alkylation and identification of the histidine residues at the active site of ribonuclease. J Biol Chem. 1963 Jul;238:2413–2419. [PubMed] [Google Scholar]
  3. Denzlinger C., Guhlmann A., Scheuber P. H., Wilker D., Hammer D. K., Keppler D. Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem. 1986 Nov 25;261(33):15601–15606. [PubMed] [Google Scholar]
  4. Ende I. A., Terplan G., Kickhöfen B., Hammer D. K. Chromatofocusing: a new method for purification of staphylococcal enterotoxins B and C1. Appl Environ Microbiol. 1983 Dec;46(6):1323–1330. doi: 10.1128/aem.46.6.1323-1330.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gehl R., Bartsch K., Hammer D., Himmelspach K. MOPC 104E IgM/anti-idiotype solid-phase inhibition assay as a model for screening myeloma proteins for ligand binding specificity. J Immunol Methods. 1981;42(2):243–249. doi: 10.1016/0022-1759(81)90154-x. [DOI] [PubMed] [Google Scholar]
  6. Guillet J. G., Kaveri S. V., Durieu O., Delavier C., Hoebeke J., Strosberg A. D. beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody. Proc Natl Acad Sci U S A. 1985 Mar;82(6):1781–1784. doi: 10.1073/pnas.82.6.1781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harris C. M., Hillrl The carboxymethylation of human metmyoglobin. J Biol Chem. 1969 Apr 25;244(8):2195–2203. [PubMed] [Google Scholar]
  8. Homcy C. J., Rockson S. G., Haber E. An antiidiotypic antibody that recognizes the beta-adrenergic receptor. J Clin Invest. 1982 May;69(5):1147–1154. doi: 10.1172/JCI110550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Marasco W. A., Becker E. L. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil. J Immunol. 1982 Feb;128(2):963–968. [PubMed] [Google Scholar]
  10. Parham P. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol. 1983 Dec;131(6):2895–2902. [PubMed] [Google Scholar]
  11. Scheuber P. H., Denzlinger C., Wilker D., Beck G., Keppler D., Hammer D. K. Cysteinyl leukotrienes as mediators of staphylococcal enterotoxin B in the monkey. Eur J Clin Invest. 1987 Oct;17(5):455–459. doi: 10.1111/j.1365-2362.1987.tb01142.x. [DOI] [PubMed] [Google Scholar]
  12. Scheuber P. H., Golecki J. R., Kickhöfen B., Scheel D., Beck G., Hammer D. K. Skin reactivity of unsensitized monkeys upon challenge with staphylococcal enterotoxin B: a new approach for investigating the site of toxin action. Infect Immun. 1985 Dec;50(3):869–876. doi: 10.1128/iai.50.3.869-876.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schuler W., Weiler E., Kolb H. Characterization of syngeneic anti-idiotypic antibody against the idiotype fo BALB/c myeloma protein J558. Eur J Immunol. 1977 Sep;7(9):649–654. doi: 10.1002/eji.1830070914. [DOI] [PubMed] [Google Scholar]
  14. Sege K., Peterson P. A. Use of anti-idiotypic antibodies as cell-surface receptor probes. Proc Natl Acad Sci U S A. 1978 May;75(5):2443–2447. doi: 10.1073/pnas.75.5.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Shanahan F., Denburg J. A., Fox J., Bienenstock J., Befus D. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol. 1985 Aug;135(2):1331–1337. [PubMed] [Google Scholar]
  16. Stelma G. N., Jr, Bergdoll M. S. Inactivation of staphylococcal enterotoxin A by chemical modification. Biochem Biophys Res Commun. 1982 Mar 15;105(1):121–126. doi: 10.1016/s0006-291x(82)80019-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES